Sovremennye podkhody k terapii depressiy

Abstract

The data suggesting that there has been a rise in the number of patients with depressions in the past two decades are analyzed. A tendency towards the chronic course of monopolar depressions and the disabling pattern of these affective disorders are noted. Some pathogenetic mechanisms for development of depressive disorders are considered. Analysis of the results of current clinical psychopharmacological studies has yielded information on the drugs that have high antidepressant activity and cause mild adverse reactions.

Keywords

depression / serotonin / noradrenaline / antidepressants

References

[1] Мосолов С. Н. Клиническое применение современных антидепрессантов. - СПб., 1995.

[2] Angst J., Preisig M. // Schweiz. Arch. Neurol. Psychiatr. - 1995. - Vol. 146, N 1. - P. 17-23.

[3] Artigas F., Nutt D. J., Shelton R. // Psychopharmacol. Bull. - 2002. - Vol. 36. - Suppl. 2. - P. 123-132.

[4] Detke M. J., Lu Y., Goldstein D. J. et al. // J. Clin. Psychiatry. - 2002. - Vol. 63, N 4. - P. 308-315.

[5] Gorman J. M. // J. Clin. Psychiatry. - 1999. - Vol. 60. - Suppl. 17. - P. 9-13.

[6] Hirschfeld R. M. A. // J. Clin. Psychiatry. - 1994. - Suppl. 12. - P. 61-69.

[7] Monteleone P., Maj M. // Medicographia. - 2009. - Vol. 31, N 2. - P. 132-139.

[8] Munoz C. // Medicographia. - 2009. - Vol. 31, N 2. - P. 175-181.

[9] Murray C. J., Lopez A. D. // Lancet. - 1997. - Vol. 349. - P. 1498-1504.

[10] Schildkraut J. J. // Am. J. Psychiatry. - 1965. - Vol. 122. - P. 509-522.

[11] Spinney L. // Eur. Psychiatry. - 2009. - Vol. 24, N 8. - P. 550-551.

[12] Stahl S. M., Plezenberg A. A., Gorman G. M. // J. Clin. Psychiatry. - 2001. - Vol. 62. - P. 17-23.

[13] Thase M. E., Entsuah A. R., Rudolph R. L. // Br. J. Psychiatry. - 2001. - Vol. 178. - P. 234-241.

[14] Wittchen H. U., Jacobi F. // Eur. Neuropsychopharmacol. - 2005. - Vol. 15. - P. 357-376.

RIGHTS & PERMISSIONS

Eco-Vector